Stay updated on Pembrolizumab +/- Radiation in Adenoid Cystic Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab +/- Radiation in Adenoid Cystic Carcinoma Clinical Trial page.

Latest updates to the Pembrolizumab +/- Radiation in Adenoid Cystic Carcinoma Clinical Trial page
- Check2 days agoChange DetectedOnly a version bump from v3.0.0 to v3.0.2; no other content changes detected.SummaryDifference0.1%
- Check16 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as new content related to radiation exposure and adrenal cortex carcinoma. Notably, the revision number has been updated to v3.0.0.SummaryDifference2%
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check45 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.8%
- Check52 days agoChange DetectedThe web page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, and it now includes a section on HHS Vulnerability Disclosure.SummaryDifference0.1%
Stay in the know with updates to Pembrolizumab +/- Radiation in Adenoid Cystic Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab +/- Radiation in Adenoid Cystic Carcinoma Clinical Trial page.